Analyzing risk factors for intrahepatic cholangiocarcinoma

Hepatology

Volumn 58, Issue 5, 2013, Pages 1862-1863

  Fujita, Tetsuji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

BILE DUCT CARCINOMA; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; LETTER; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

CHOLANGIOCARCINOMA; DIABETES MELLITUS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; METFORMIN;

EID: 84887018650     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26448     Document Type: Letter

References (3)

1. Chaiteerakij R, Yang JO, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, et al. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology 2013;57:648-655.
2. Breslow NE. Case-control studies. In: Pigeot AW, ed. Handbook of Epidemiology. Berlin: Springer; 2005:287-319.
3. Centers for Disease Control and Prevention. Prevalence of cholesterol screening and high blood cholesterol among adults-United States, 2005, 2007, and 2009. MMWR Morb Mortal Wkly Rep 2012;61:697-702.